Literature DB >> 22503000

How can elderly apolipoprotein E ε4 carriers remain free from dementia?

Camilla Ferrari1, Wei-Li Xu, Hui-Xin Wang, Bengt Winblad, Sandro Sorbi, Chengxuan Qiu, Laura Fratiglioni.   

Abstract

Apolipoprotein E (APOE) ε4 is a major risk factor for Alzheimer's disease (AD) and dementia, but not all ε4 carriers develop dementia. We sought to identify factors that may play a role in modifying the risk of dementia due to ε4. A cognitively intact cohort (n = 932, age ≥ 75) was followed for 9 years to detect incident dementia cases. At baseline, information on education, leisure activities, and vascular risk factors was collected, and APOE was genotyped. During the follow-up, 324 subjects developed dementia, including 247 AD cases. The hazard ratio (HR, 95% confidence interval [95% CI]) of dementia related to the ε4 was 1.39 (1.11-1.76), while the risk was reduced when ε4 carriers had high education, no vascular risk factors, or high score of leisure activities. Among ε4 carriers, the multiadjusted HRs of dementia that were associated with high education, high level of leisure activities, and absence of vascular risk factors were 0.59 (0.40-0.87), 0.49 (0.29-0.85), and 0.61 (0.41-0.90), respectively. The ε4 carriers with these factors had about 1.2 years delayed time to dementia onset compared with those without these factors. High education, active leisure activities, or maintaining vascular health seems to reduce the risk of dementia related to APOE ε4. The ε4 carriers with these characteristics appear to have similar dementia-free survival time to non-ε4 carriers.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22503000     DOI: 10.1016/j.neurobiolaging.2012.03.003

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  22 in total

Review 1.  Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy.

Authors:  Chia-Chen Liu; Chia-Chan Liu; Takahisa Kanekiyo; Huaxi Xu; Guojun Bu
Journal:  Nat Rev Neurol       Date:  2013-01-08       Impact factor: 42.937

2.  Effects of APOE on cognitive aging in community-dwelling older adults.

Authors:  Emilie T Reas; Gail A Laughlin; Jaclyn Bergstrom; Donna Kritz-Silverstein; Elizabeth Barrett-Connor; Linda K McEvoy
Journal:  Neuropsychology       Date:  2019-02-07       Impact factor: 3.295

3.  APOE moderates the association between lifestyle activities and cognitive performance: evidence of genetic plasticity in aging.

Authors:  Shannon K Runge; Brent J Small; G Peggy McFall; Roger A Dixon
Journal:  J Int Neuropsychol Soc       Date:  2014-05       Impact factor: 2.892

4.  In Thai Nationals, the ApoE4 Allele Affects Multiple Domains of Neuropsychological, Biobehavioral, and Social Functioning Thereby Contributing to Alzheimer's Disorder, while the ApoE3 Allele Protects Against Neuropsychiatric Symptoms and Psychosocial Deficits.

Authors:  Sookjaroen Tangwongchai; Thitiporn Supasitthumrong; Solaphat Hemrunroj; Chavit Tunvirachaisakul; Phenphichcha Chuchuen; Natnicha Houngngam; Thiti Snabboon; Ittipol Tawankanjanachot; Yuthachai Likitchareon; Kamman Phanthumchindad; Michael Maes
Journal:  Mol Neurobiol       Date:  2018-01-06       Impact factor: 5.590

5.  Cognitive resilience among APOE ε4 carriers in the oldest old.

Authors:  Kathleen M Hayden; Sarah A Gaussoin; Jaimie C Hunter; JoAnn E Manson; Bonnie C Sachs; Aladdin H Shadyab; Hilary A Tindle; Yasmin Mossavar-Rahmani; Khyobeni Mozhui; Beverly M Snively; Stephen R Rapp; Susan M Resnick
Journal:  Int J Geriatr Psychiatry       Date:  2019-08-22       Impact factor: 3.485

6.  Cognitive resilience to apolipoprotein E ε4: contributing factors in black and white older adults.

Authors:  Allison R Kaup; Jasmine Nettiksimmons; Tamara B Harris; Kaycee M Sink; Suzanne Satterfield; Andrea L Metti; Hilsa N Ayonayon; Kristine Yaffe
Journal:  JAMA Neurol       Date:  2015-03       Impact factor: 18.302

7.  Bridging the Translation Gap: From Dementia Risk Assessment to Advice on Risk Reduction.

Authors:  Kaarin J Anstey; Ranmalee Eramudugolla; Diane E Hosking; Nicola T Lautenschlager; Roger A Dixon
Journal:  J Prev Alzheimers Dis       Date:  2015

8.  Relationship of cognitive reserve and APOE status to the emergence of clinical symptoms in preclinical Alzheimer's disease.

Authors:  Corinne Pettigrew; Anja Soldan; Shanshan Li; Yi Lu; Mei-Cheng Wang; Ola A Selnes; Abhay Moghekar; Richard O'Brien; Marilyn Albert
Journal:  Cogn Neurosci       Date:  2013-08-25       Impact factor: 3.065

9.  Cognitive reserve and long-term change in cognition in aging and preclinical Alzheimer's disease.

Authors:  Anja Soldan; Corinne Pettigrew; Qing Cai; Jiangxia Wang; Mei-Cheng Wang; Abhay Moghekar; Michael I Miller; Marilyn Albert
Journal:  Neurobiol Aging       Date:  2017-09-11       Impact factor: 4.673

Review 10.  Resistance vs resilience to Alzheimer disease: Clarifying terminology for preclinical studies.

Authors:  Eider M Arenaza-Urquijo; Prashanthi Vemuri
Journal:  Neurology       Date:  2018-03-28       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.